Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06ZNX
|
|||
Former ID |
DNC008281
|
|||
Drug Name |
2,2,2-tris-(3-fluorophenyl)-acetamide
|
|||
Synonyms |
CHEMBL260736; SCHEMBL13950949
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H14F3NO
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)F)C(C2=CC(=CC=C2)F)(C3=CC(=CC=C3)F)C(=O)N
|
|||
InChI |
1S/C20H14F3NO/c21-16-7-1-4-13(10-16)20(19(24)25,14-5-2-8-17(22)11-14)15-6-3-9-18(23)12-15/h1-12H,(H2,24,25)
|
|||
InChIKey |
NYTZBODQYAXXMZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calcium-activated potassium channel (KCN) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.